Novo Nordisk to slash list prices of Ozempic, Wegovy by up to 50%
Novo Nordisk announced up to 50% price cuts for Ozempic and Wegovy diabetes and weight-loss drugs starting January 2027, lowering costs to $675 per dose.
Johnson & Johnson to invest $1B in Pennsylvania manufacturing facility
Johnson & Johnson announced a $1 billion investment in a Montgomery County, Pennsylvania, cell therapy facility that will yield over 500 manufacturing jobs plus 4,000 construction jobs.
Trump-era FDA clears path for Moderna flu vaccine review after regulatory standoff
Moderna President Dr. Stephen Hoge joins ‘Mornings with Maria’ to discuss the FDA’s decision to review the company’s mRNA flu vaccine, new cancer vaccine breakthroughs and what’s next for growth in the US and abroad.
Cheerios maker says cost of living, housing expenses changing way consumers spend
General Mills trimmed its full-year forecast as consumers rethink grocery spending, seek better-for-you foods and slow purchases of traditional packaged brands.
Dagen McDowell: AI, nation need to deal with exploding health care cost in order to continue existing
'The Big Money Show' panel analyzes the 'gray-shaped economy' and the January jobs report.
Amazon Pharmacy to expand same-day prescription delivery to 4,500 US cities
Amazon plans to expand same-day prescription delivery to nearly 4,500 US cities by 2026, adding 2,000 communities and expanding savings programs.
FDA eyes ban on BHA preservative found in 4,600 foods amid cancer concerns, commissioner says
FDA Commissioner Dr. Marty Makary joins ‘Varney & Co.’ to discuss the agency’s review of cancer-linked food additives, rising teen THC vaping and concerns over Moderna’s mRNA flu shot trial.
Novo CEO outlines long-term strategy amid Trump-era drug talks: ‘We’re here to stay’
Novo Nordisk President and CEO Mike Doustdar joins ‘Mornings with Maria’ to discuss the launch of the first GLP-1 weight-loss pill in the U.S., the lawsuit against Hims & Hers and talks with the Trump administration on drug pricing.
Hims & Hers responds to FDA pressure, pulls knockoff Wegovy drug launch after regulatory threats
Telehealth company Hims & Hers cancels $49 monthly weight-loss drug launch following FDA warnings about unapproved semaglutide compounds and Novo threats.
Trump announces launch of discount drug website: TrumpRx.gov
'The Big Money Show' discusses President Donald Trump's announcement of the TrumpRx.gov website and his efforts to lower prescription costs.
President launches TrumpRx.gov website offering Americans discounted prescription drug prices: ‘Historic’
President Donald Trump unveils TrumpRx.gov with 16 pharmaceutical companies slashing prescription drug prices, including Wegovy, dropping from $1,300 to $199 monthly.
Trump to unveil TrumpRx website where Americans can purchase prescription drugs
President Donald Trump is set to unveil a government website on Thursday that will help Americans buy prescription drugs at lower costs.
Moderna, Merck report cancer vaccine breakthrough in melanoma trial
Moderna CEO Stéphane Bancel discusses positive cancer vaccine trial results and the impact GLP-1 drugs on 'Mornings with Maria.'
Pfizer CEO addresses growing competition in weight-loss drugs
Pfizer CEO Albert Bourla discusses Pfizer’s Q4 adjusted earnings and the competitive landscape for weight-loss drugs on ‘The Claman Countdown.’
Nearly 150K multivitamin bottles recalled over packaging violation
Mindbodygreen's recall covers 148,370 Ultimate Multivitamin+ bottles due to non-child-resistant packaging that could result in the poisoning of a young child.
Obamacare enrollment fell by more than 1M enrollees for 2026
Obamacare enrollment projected to drop by over 1 million Americans as health insurance premiums surge following the end of COVID-era federal subsidies in 2026.
Thousands of cholesterol drug bottles recalled nationwide over manufacturing defects
Tens of thousands of cholesterol medication bottles are being recalled nationwide due to manufacturing issues that could reduce drug potency and effectiveness.
Cytokinetics' heart drug hits market after FDA approval
Cytokinetics President and CEO Robert Blum discusses the state of cardiovascular care in America on 'Mornings with Maria.'
US set to exit WHO as unpaid fees remain and legal hurdles mount ahead
The U.S. is set to officially exit the World Health Organization as questions remain over unpaid fees and legal requirements.
Trump administration takes aim at sky-high drug costs with ‘Most Favored Nation’ plan
Centers for Medicare & Medicaid Services Administrator Dr. Mehmet Oz joins ‘Mornings with Maria’ to break down President Donald Trump’s plan to slash drug prices, crack down on Medicaid fraud and lower healthcare costs for Americans.